Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Eddie Underwood, Lisa M. Dunkle, Shabir A. Madhi, Cynthia L. Gay, Paul T. Heath, Karen L. Kotloff, Katherine Smith, Gordon Chau, Shirley Galbiati, Alice McGarry, Wayne Woo, Iksung Cho, Katia Alves, Germán Áñez, Chijioke Bennett, Vivek Shinde, Louis Fries, Raburn M. Mallory, Gregory M. Glenn & Seth Toback. (2023) Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Expert Review of Vaccines 22:1, pages 501-517.
Read now
Read now
Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, Berit Carow, Carolina Lunderius Andersson, Sofia E. Magnusson, Cecilia Carnrot, Vivek Shinde, Gale Smith, Gregory Glenn, Louis Fries & Karin Lövgren Bengtsson. (2023) The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Ji-Hui Zhao, Qi-Bo Zhang, Bao Liu, Xiang-Hua Piao, Yu-Lu Yan, Xiao-Ge Hu, Kuan Zhou, Yong-Tai Zhang & Nian-Ping Feng. (2017) Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant. International Journal of Nanomedicine 12, pages 4763-4772.
Read now
Read now
Jing Hu, Liying Qiu, Xiaoli Wang, Xiaopeng Zou, Mengji Lu & Jian Yin. (2015) Carbohydrate-based vaccine adjuvants – discovery and development. Expert Opinion on Drug Discovery 10:10, pages 1133-1144.
Read now
Read now
Rachel Buglione-Corbett, Kimberly Pouliot, Robyn Marty-Roix, Wei Li, Kim West, Shixia Wang, Adriana Baz Morelli, Egil Lien & Shan Lu. (2014) Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine. Human Vaccines & Immunotherapeutics 10:4, pages 1078-1090.
Read now
Read now
Adele Mount, Sandra Koernig, Anabel Silva, Debbie Drane, Eugene Maraskovsky & Adriana Baz Morelli. (2013) Combination of adjuvants: the future of vaccine design. Expert Review of Vaccines 12:7, pages 733-746.
Read now
Read now
Govind Ragupathi, Jeffrey R Gardner, Philip O Livingston & David Y Gin. (2011) Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. Expert Review of Vaccines 10:4, pages 463-470.
Read now
Read now
Carla Herberts, Barbro Melgert, Jan Willem van der Laan & Marijke Faas. (2010) New adjuvanted vaccines in pregnancy: what is known about their safety?. Expert Review of Vaccines 9:12, pages 1411-1422.
Read now
Read now
Girishchandra B Patel & Wangxue Chen. (2010) Archaeal lipid mucosal vaccine adjuvant and delivery system. Expert Review of Vaccines 9:4, pages 431-440.
Read now
Read now
M Dauer, M Schnurr & A Eigler. (2008) Dendritic cell-based cancer vaccination: quo vadis?. Expert Review of Vaccines 7:7, pages 1041-1053.
Read now
Read now
Articles from other publishers (81)
Meng-Qun Cheng, Rong Li, Xin Luo, Jing-Yu Chen, Zhong-Ping Bai, Pin Zhao, Zhi-Ying Weng & Gao Song. (2023) Immunogenicity and safety of adjuvant-associated COVID-19 vaccines: A systematic review and meta-analysis of randomized controlled trials. Heliyon 9:12, pages e22858.
Crossref
Crossref
Nian Liu, Xiangyu Xiao, Ziqiang Zhang, Chun Mao, Mimi Wan & Jian Shen. (2023) Advances in Cancer Vaccine Research. ACS Biomaterials Science & Engineering 9:11, pages 5999-6023.
Crossref
Crossref
Elmas Pınar KAHRAMAN KILBAŞ & Mustafa ALTINDİŞ. (2023) Mevcut ve Gelişmekte Olan Aşı Teknolojileri; Kısa derlemeCurrent and Emerging Vaccine Technologies; A short review. Journal of Biotechnology and Strategic Health Research 7:3, pages 148-156.
Crossref
Crossref
Erwin G. Abucayon, Rodell C. Barrientos, Oscar B. Torres, Scott Sweeney, Connor Whalen & Gary R. Matyas. (2023) A Liquid Chromatography High-Resolution Tandem Mass Spectrometry Method to Quantify QS-21 Adjuvant and Its Degradation Products in Liposomal Drug Formulations. ACS Omega 8:23, pages 21016-21025.
Crossref
Crossref
Xiaojin Chen, Xudong Fan & Fanzhu Li. (2022) Development and Evaluation of a Novel Diammonium Glycyrrhizinate Phytosome for Nasal Vaccination. Pharmaceutics 14:10, pages 2000.
Crossref
Crossref
Jiahuan Li, Ge Yu, Zhihui Liang, Min Li, Chen Chen, Xin Li, Yiyang Guo, Cheng Yang, Yang Liu, Caiqiao Zhang, Weiting Zhang, Jiaxu Liu, Xuehu Ma, Changying Xue & Bingbing Sun. (2022) Mechanistic elucidation of freezing-induced surface decomposition of aluminum oxyhydroxide adjuvant. iScience 25:6, pages 104456.
Crossref
Crossref
Maria Florencia Pacini, Florencia Belén González, Brenda Dinatale, Camila Bulfoni Balbi, Silvina Raquel Villar, Cecilia Farré, Giuliana Lupi, Martín Espariz, Víctor Sebastián Blancato, Christian Magni, Iván Marcipar & Ana Rosa Pérez. (2022) Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection. Vaccine 40:15, pages 2311-2323.
Crossref
Crossref
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Fatai S. Oladunni, Saheed Oluwasina Oseni, Luis Martinez-Sobrido & Thomas M. Chambers. (2021) Equine Influenza Virus and Vaccines. Viruses 13:8, pages 1657.
Crossref
Crossref
Maria Montoya & Elma Z. Tchilian. 2021. Veterinary Vaccines. Veterinary Vaccines
11
23
.
Adele M. Barr, Anabel Silva, Sandro Prato, Gabrielle T. Belz, Eugene Maraskovsky & Adriana Baz Morelli. (2020) Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer. Cancer Immunology, Immunotherapy 69:10, pages 1959-1972.
Crossref
Crossref
Tonke K Raaijmakers, Renske J E van den Bijgaart, Martijn H den Brok, Melissa Wassink, Annemarie de Graaf, Jori A Wagenaars, Stefan Nierkens, Marleen Ansems, Gert Jan Scheffer & Gosse J Adema. (2020) Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes. Journal for ImmunoTherapy of Cancer 8:1, pages e000649.
Crossref
Crossref
Jonathan S Cebon, Martin Gore, John F Thompson, Ian D Davis, Grant A McArthur, Euan Walpole, Mark Smithers, Vincenzo Cerundolo, P Rod Dunbar, Duncan MacGregor, Cyril Fisher, Michael Millward, Paul Nathan, Michael P N Findlay, Peter Hersey, T R Jeffry Evans, Christian Hermann Ottensmeier, Jeremy Marsden, Angus G Dalgleish, Pippa G Corrie, Marples Maria, Margaret Brimble, Geoff Williams, Sintia Winkler, Heather M Jackson, Liliana Endo-Munoz, Candani S A Tutuka, Ralph Venhaus, Lloyd J Old, Dennis Haack, Eugene Maraskovsky, Andreas Behren & Weisan Chen. (2020) Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. Journal for ImmunoTherapy of Cancer 8:1, pages e000410.
Crossref
Crossref
Tyson J. Moyer, Yu Kato, Wuhbet Abraham, Jason Y. H. Chang, Daniel W. Kulp, Nicki Watson, Hannah L. Turner, Sergey Menis, Robert K. Abbott, Jinal N. Bhiman, Mariane B. Melo, Hayley A. Simon, Sara Herrera-De la Mata, Shu Liang, Gregory Seumois, Yash Agarwal, Na Li, Dennis R. Burton, Andrew B. Ward, William R. Schief, Shane Crotty & Darrell J. Irvine. (2020) Engineered immunogen binding to alum adjuvant enhances humoral immunity. Nature Medicine 26:3, pages 430-440.
Crossref
Crossref
Minyu Wang, Sen Wang, Jayesh Desai, Joseph A Trapani & Paul J Neeson. (2020) Therapeutic strategies to remodel immunologically cold tumors. Clinical & Translational Immunology 9:12.
Crossref
Crossref
Cynthia Calzas & Christophe Chevalier. (2019) Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Frontiers in Immunology 10.
Crossref
Crossref
J Wallis, D P Shenton & R C Carlisle. (2019) Novel approaches for the design, delivery and administration of vaccine technologies. Clinical and Experimental Immunology 196:2, pages 189-204.
Crossref
Crossref
Aloysious Ssemaganda, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski, Istvan Toth, Danielle I. Stanisic & Michael F. Good. (2019) Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines. Frontiers in Immunology 10.
Crossref
Crossref
Ting Liu, Rui Qian, Qingchuan Liu, Tingni Wu & Jialong Chen. 2018. Immunization - Vaccine Adjuvant Delivery System and Strategies. Immunization - Vaccine Adjuvant Delivery System and Strategies.
Ying Liu, Ling Ye, Fang Lin, Yasmine Gomaa, David Flyer, Ricardo CarrionJr.Jr., Jean L Patterson, Mark R Prausnitz, Gale Smith, Gregory Glenn, Hua Wu, Richard W Compans & Chinglai Yang. (2018) Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge. The Journal of Infectious Diseases 218:suppl_5, pages S545-S552.
Crossref
Crossref
Mona Kabiri, Mojtaba Sankian, Mitra Hosseinpour & Mohsen Tafaghodi. (2018) The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1. International Journal of Pharmaceutics 549:1-2, pages 404-414.
Crossref
Crossref
Samuel Paulo Cibulski, Mariana Rivera-Patron, Gustavo Mourglia-Ettlin, Cecilia Casaravilla, Anna Carolina Alves Yendo, Arthur Germano Fett-Neto, José Alejandro Chabalgoity, María Moreno, Paulo Michel Roehe & Fernando Silveira. (2018) Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses. Scientific Reports 8:1.
Crossref
Crossref
Ying Liu, Ling Ye, Fang Lin, Yasmine Gomaa, David Flyer, Ricardo CarrionJr.Jr., Jean L. Patterson, Mark R. Prausnitz, Gale Smith, Gregory Glenn, Hua Wu, Richard W. Compans & Chinglai Yang. (2018) Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge. Scientific Reports 8:1.
Crossref
Crossref
Luke J. Norbury, Katarzyna Basałaj, Anna Zawistowska-Deniziak, Alicja Sielicka, Przemysław Wilkowski, Agnieszka Wesołowska, Peter M. Smooker & Halina Wędrychowicz. (2018) Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep. Veterinary Parasitology 258, pages 14-23.
Crossref
Crossref
Martijn H. den Brok, Tonke K. Raaijmakers, Estel Collado-Camps & Gosse J. Adema. (2018) Lipid Droplets as Immune Modulators in Myeloid Cells. Trends in Immunology 39:5, pages 380-392.
Crossref
Crossref
Blaise Corthésy & Gilles Bioley. (2018) Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Frontiers in Immunology 9.
Crossref
Crossref
Anita Milicic, Christine S. Rollier, Choon Kit Tang, Rhea Longley, Adrian V. S. Hill & Arturo Reyes-Sandoval. (2017) Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria. Scientific Reports 7:1.
Crossref
Crossref
Ivan Bontempi, Pedro Fleitas, Alexia Poato, Miguel Vicco, Luz Rodeles, Estefania Prochetto, Gabriel Cabrera, Bruno Beluzzo, Diego Arias, Andrea Racca, Sergio Guerrero & Iván Marcipar. (2017)
Trans-sialidase overcomes many antigens to be used as a vaccine candidate against
Trypanosoma cruzi
. Immunotherapy 9:7, pages 555-565.
Crossref
Crossref
Ruchi R. Shah, Kimberly J. Hassett & Luis A. Brito. 2017. Vaccine Adjuvants. Vaccine Adjuvants
1
13
.
Patricia Jorquera & Ralph Tripp. (2016) Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus. Vaccines 4:4, pages 45.
Crossref
Crossref
Francesco Manfredi, Paola di Bonito, Barbara Ridolfi, Simona Anticoli, Claudia Arenaccio, Chiara Chiozzini, Adriana Baz Morelli & Maurizio Federico. (2016) The CD8+ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant. Vaccines 4:4, pages 42.
Crossref
Crossref
Martijn H. den Brok, Christian Büll, Melissa Wassink, Annemarie M. de Graaf, Jori A. Wagenaars, Marthe Minderman, Mayank Thakur, Sebastian Amigorena, Eric O. Rijke, Carla C. Schrier & Gosse J. Adema. (2016) Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation. Nature Communications 7:1.
Crossref
Crossref
Duk Kyung Kim, Kyeong Hye Won, Seung Hyun Moon & Hak-Kyo Lee. (2015) Identification of Molecular Signatures from Different Vaccine Adjuvants in Chicken by Integrative Analysis of Microarray Data. Asian-Australasian Journal of Animal Sciences 29:7, pages 1044-1051.
Crossref
Crossref
Emilia Bigaeva, Eva van Doorn, Heng Liu & Eelko Hak. (2016) Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability. PLOS ONE 11:5, pages e0154757.
Crossref
Crossref
Dhanasekaran Govindarajan, Steven Meschino, Liming Guan, David E. Clements, Jan H. ter Meulen, Danilo R. Casimiro, Beth-Ann G. Coller & Andrew J. Bett. (2015) Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates. Vaccine 33:33, pages 4105-4116.
Crossref
Crossref
Anabel Silva, Adele Mount, Karoline Krstevska, David Pejoski, Matthew P. Hardy, Catherine Owczarek, Pierre Scotney, Eugene Maraskovsky & Adriana Baz Morelli. (2015) The Combination of ISCOMATRIX Adjuvant and TLR Agonists Induces Regression of Established Solid Tumors In Vivo. The Journal of Immunology 194:5, pages 2199-2207.
Crossref
Crossref
Iván Alejandro Bontempi, Miguel Hernán Vicco, Gabriel Cabrera, Silvina Raquel Villar, Florencia Belén González, Eduardo Angel Roggero, Paul Ameloot, Nico Callewaert, Ana Rosa Pérez & Iván Sergio Marcipar. (2015) Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease. Vaccine 33:10, pages 1274-1283.
Crossref
Crossref
C. McEntee, E.C. Lavelle & D.T. O’Hagan. 2015. Mucosal Immunology. Mucosal Immunology
1211
1231
.
Luis A. Brito & Derek T. O'Hagan. (2014) Designing and building the next generation of improved vaccine adjuvants. Journal of Controlled Release 190, pages 563-579.
Crossref
Crossref
Nani Wibowo, Yap P. Chuan, Arjun Seth, Yoann Cordoba, Linda H.L. Lua & Anton P.J. Middelberg. (2014) Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation. Vaccine 32:29, pages 3664-3669.
Crossref
Crossref
Nicholas S. Wilson, Peter Duewell, Becky Yang, Yun Li, Scot Marsters, Sandra Koernig, Eicke Latz, Eugene Maraskovsky, Adriana Baz Morelli, Max Schnurr & Avi Ashkenazi. (2014) Inflammasome-Dependent and -Independent IL-18 Production Mediates Immunity to the ISCOMATRIX Adjuvant. The Journal of Immunology 192:7, pages 3259-3268.
Crossref
Crossref
Kylie M. Quinn, Ayako Yamamoto, Andreia Costa, Patricia A. Darrah, Ross W. B. Lindsay, Sonia T. Hegde, Teresa R. Johnson, Barbara J. Flynn, Karin Loré & Robert A. Seder. (2013) Coadministration of Polyinosinic:Polycytidylic Acid and Immunostimulatory Complexes Modifies Antigen Processing in Dendritic Cell Subsets and Enhances HIV Gag-Specific T Cell Immunity. The Journal of Immunology 191:10, pages 5085-5096.
Crossref
Crossref
Daniel DiStefano, Joseph M. Antonello, Andrew J. Bett, Muneeswara B. Medi, Danilo R. Casimiro & Jan ter Meulen. (2013) Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques. Vaccine 31:42, pages 4888-4893.
Crossref
Crossref
Francesco Berti & Roberto Adamo. (2013) Recent Mechanistic Insights on Glycoconjugate Vaccines and Future Perspectives. ACS Chemical Biology 8:8, pages 1653-1663.
Crossref
Crossref
Ofer Levy, Stanislas Goriely & Tobias R. Kollmann. (2013) Immune response to vaccine adjuvants during the first year of life. Vaccine 31:21, pages 2500-2505.
Crossref
Crossref
Gregory A. Poland, Douglas M. Fleming, John J. Treanor, Eugene Maraskovsky, Thomas C. Luke, Emma M.A. Ball & Caroline M. Poland. (2013) New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Vaccine 31, pages A1-A20.
Crossref
Crossref
Mehfuz Zaman, Saranya Chandrudu & Istvan Toth. (2012) Strategies for intranasal delivery of vaccines. Drug Delivery and Translational Research 3:1, pages 100-109.
Crossref
Crossref
Jayanthi J. Wolf, Lisa M. Plitnick & Danuta J. Herzyk. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
323
349
.
Tong-Ming Fu, Dai Wang, Daniel C. Freed, Aimin Tang, Fengsheng Li, Xi He, Suzanne Cole, Sheri Dubey, Adam C. Finnefrock, Jan ter Meulen, John W. Shiver & Danilo R. Casimiro. (2012) Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. Vaccine 30:52, pages 7469-7474.
Crossref
Crossref
Eric K. Chea, Alberto Fernández-Tejada, Payal Damani, Michelle M. Adams, Jeffrey R. Gardner, Philip O. Livingston, Govind Ragupathi & David Y. Gin. (2012) Synthesis and Preclinical Evaluation of QS-21 Variants Leading to Simplified Vaccine Adjuvants and Mechanistic Probes. Journal of the American Chemical Society 134:32, pages 13448-13457.
Crossref
Crossref
Jenny M. Reimer, Karin H. Karlsson, Karin Lövgren-Bengtsson, Sofia E. Magnusson, Alexis Fuentes & Linda Stertman. (2012) Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen. PLoS ONE 7:7, pages e41451.
Crossref
Crossref
Adriana Baz Morelli, Dorit Becher, Sandra Koernig, Anabel Silva, Debbie Drane & Eugene Maraskovsky. (2012) ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases. Journal of Medical Microbiology 61:7, pages 935-943.
Crossref
Crossref
Marina Zaitseva, Tatiana Romantseva, Ksenia Blinova, Joel Beren, Lev Sirota, Debbie Drane & Hana Golding. (2012) Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo. Vaccine 30:32, pages 4859-4865.
Crossref
Crossref
Nicholas S Wilson, Becky Yang, Adriana Baz Morelli, Sandra Koernig, Annie Yang, Stefanie Loeser, Denise Airey, Larissa Provan, Phil Hass, Hal Braley, Suzana Couto, Debbie Drane, Jeff Boyle, Gabrielle T Belz, Avi Ashkenazi & Eugene Maraskovsky. (2011)
ISCOMATRIX vaccines mediate CD8
+
T‐cell cross‐priming by a MyD88‐dependent signaling pathway
. Immunology & Cell Biology 90:5, pages 540-552.
Crossref
Crossref
Ennio De Gregorio & Rino Rappuoli. (2012) Vaccines for the future: learning from human immunology. Microbial Biotechnology 5:2, pages 149-155.
Crossref
Crossref
Ana Vujanic, Kenneth J. Snibson, Janet L. K. Wee, Stirling J. Edwards, Martin J. Pearse, Jean-Pierre Y. Scheerlinck & Philip Sutton. (2012) Long-Term Antibody and Immune Memory Response Induced by Pulmonary Delivery of the Influenza Iscomatrix Vaccine. Clinical and Vaccine Immunology 19:1, pages 79-83.
Crossref
Crossref
Martijn H. den Brok, Stefan Nierkens, Jori A. Wagenaars, Theo J. Ruers, Carla C. Schrier, Eric O. Rijke & Gosse J. Adema. (2012) Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction. Vaccine 30:4, pages 737-744.
Crossref
Crossref
Rebecca J. Cox, Gabriel Pedersen, Abdullah S. Madhun, Signe Svindland, Marianne Sævik, Lucy Breakwell, Katja Hoschler, Marieke Willemsen, Laura Campitelli, Jane Kristin Nøstbakken, Gerrit Jan Weverling, Jaco Klap, Kenneth C. McCullough, Maria Zambon, Ronald Kompier & Haakon Sjursen. (2011) Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial. Vaccine 29:45, pages 8049-8059.
Crossref
Crossref
Beth-Ann G. Coller, David E. Clements, Andrew J. Bett, Sangeetha L. Sagar & Jan H. Ter Meulen. (2011) The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease. Vaccine 29:42, pages 7267-7275.
Crossref
Crossref
Peter Duewell, Ulrich Kisser, Klaus Heckelsmiller, Sabine Hoves, Patrizia Stoitzner, Sandra Koernig, Adriana B. Morelli, Björn E. Clausen, Marc Dauer, Andreas Eigler, David Anz, Carole Bourquin, Eugene Maraskovsky, Stefan Endres & Max Schnurr. (2011) ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells. The Journal of Immunology 187:1, pages 55-63.
Crossref
Crossref
Collin Jacobs, Peter Duewell, Klaus Heckelsmiller, Jiwu Wei, Franz Bauernfeind, Jonathan Ellermeier, Ulrich Kisser, Christian A. Bauer, Marc Dauer, Andreas Eigler, Eugene Maraskovsky, Stefan Endres & Max Schnurr. (2011) An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma. International Journal of Cancer 128:4, pages 897-907.
Crossref
Crossref
J. Solano-Parada, G. Gonzalez-Gonzalez, L.M. de Pablos Torró, M.F. Brazil dos Santos, A.M. Espino, M. Burgos & A. Osuna. (2010) Effectiveness of intranasal vaccination against Angiostrongylus costaricensis using a serine/threonine phosphatase 2 A synthetic peptide and recombinant antigens. Vaccine 28:32, pages 5185-5196.
Crossref
Crossref
Ana Vujanic, Janet L.K. Wee, Kenneth J. Snibson, Stirling Edwards, Martin Pearse, Charles Quinn, Margaret Moloney, Shirley Taylor, Jean-Pierre Y. Scheerlinck & Philip Sutton. (2010) Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigens. Vaccine 28:14, pages 2593-2597.
Crossref
Crossref
Michelle M. Adams, Payal Damani, Nicholas R. Perl, Annie Won, Feng Hong, Philip O. Livingston, Govind Ragupathi & David Y. Gin. (2010)
Design and Synthesis of Potent
Quillaja
Saponin Vaccine Adjuvants
. Journal of the American Chemical Society 132:6, pages 1939-1945.
Crossref
Crossref
Abdullah S. Madhun, Lars R. Haaheim, Mona V. Nilsen & Rebecca J. Cox. (2009) Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice. Vaccine 27:52, pages 7367-7376.
Crossref
Crossref
Jonathan S Anderson, Jennifer Hoy, Richard Hillman, Megan Barnden, Beng Eu, Andrew McKenzie & Charmaine Gittleson. (2009) A Randomized, Placebo-Controlled, Dose-Escalation Study to Determine the Safety, Tolerability, and Immunogenicity of an HPV-16 Therapeutic Vaccine in HIV-Positive Participants With Oncogenic HPV Infection of the Anus. JAIDS Journal of Acquired Immune Deficiency Syndromes 52:3, pages 371-381.
Crossref
Crossref
Karin Loré & Gunilla B Karlsson Hedestam. (2009) Novel adjuvants for B cell immune responses. Current Opinion in HIV and AIDS 4:5, pages 441-446.
Crossref
Crossref
J.G.M. Heldens, H.G.W. Pouwels, C.G.G. Derks, S.M.A. Van de Zande & M.J.H. Hoeijmakers. (2009) The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap. Vaccine 27:40, pages 5530-5537.
Crossref
Crossref
Deborah Middleton, Steven Rockman, Martin Pearse, Ian Barr, Sue Lowther, Jessica Klippel, David Ryan & Lorena Brown. (2009) Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization. Journal of Virology 83:15, pages 7770-7778.
Crossref
Crossref
Eugene Maraskovsky, Max Schnurr, Nick S Wilson, Neil C Robson, Jeff Boyle & Debbie Drane. (2009) Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant. Immunology & Cell Biology 87:5, pages 371-376.
Crossref
Crossref
Hong-Xiang Sun, Yong Xie & Yi-Ping Ye. (2009) ISCOMs and ISCOMATRIX™. Vaccine 27:33, pages 4388-4401.
Crossref
Crossref
Ennio De Gregorio, Ugo D’Oro & Andreas Wack. (2009) Immunology of TLR-independent vaccine adjuvants. Current Opinion in Immunology 21:3, pages 339-345.
Crossref
Crossref
Hong-Xiang Sun, Yong Xie & Yi-Ping Ye. (2009) Advances in saponin-based adjuvants. Vaccine 27:12, pages 1787-1796.
Crossref
Crossref
Max Schnurr, Martin Orban, Neil C. Robson, Amanda Shin, Hal Braley, Denise Airey, Jonathan Cebon, Eugene Maraskovsky & Stefan Endres. (2009) ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II. The Journal of Immunology 182:3, pages 1253-1259.
Crossref
Crossref
Lisa M. Ebert, Yu Chih Liu, Craig S. Clements, Neil C. Robson, Heather M. Jackson, Jessica L. Markby, Nektaria Dimopoulos, Bee Shin Tan, Immanuel F. Luescher, Ian D. Davis, Jamie Rossjohn, Jonathan Cebon, Anthony W. Purcell & Weisan Chen. (2009) A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design. Cancer Research 69:3, pages 1046-1054.
Crossref
Crossref
Robert L. Atmar & Wendy A. Keitel. 2009. Vaccines for Pandemic Influenza. Vaccines for Pandemic Influenza
323
344
.
Stacey N. Harbour, Alison L. Every, Stirling Edwards & Philip Sutton. (2008)
Systemic Immunization with Unadjuvanted Whole
Helicobacter pylori
Protects Mice Against Heterologous Challenge
. Helicobacter 13:6, pages 494-499.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:6, pages 590-596.
Crossref
Crossref
J L K Wee, J-P Y Scheerlinck, K J Snibson, S Edwards, M Pearse, C Quinn & P Sutton. (2008) Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing. Mucosal Immunology 1:6, pages 489-496.
Crossref
Crossref
Gunilla B. Karlsson Hedestam, Ron A.M. Fouchier, Sanjay Phogat, Dennis R. Burton, Joseph Sodroski & Richard T. Wyatt. (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nature Reviews Microbiology 6:2, pages 143-155.
Crossref
Crossref
Jiahuan Li, Ge Yu, Zhihui Liang, Min Li, Chen Chen, Xin Li, Yiyang Guo, Cheng Yang, Yang Liu, Caiqiao Zhang, Weiting Zhang, Jiaxu Liu, Changying Xue & Bingbing Sun. (2022) Mechanistic Elucidation of Freezing-Induced Surface Decomposition of Aluminum Oxyhydroxide Adjuvant. SSRN Electronic Journal.
Crossref
Crossref